HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 356, Issue -, Pages 649-662
Publisher
Elsevier BV
Online
2023-03-22
DOI
10.1016/j.jconrel.2023.03.026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
- (2022) Xiaojuan Zhang et al. CANCER LETTERS
- Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy
- (2022) Meitong Ou et al. JOURNAL OF CONTROLLED RELEASE
- A Multimodal Therapeutic Nanoplatform Overcoming Tumor Hypoxia Heterogeneity for Improved Tumor Chemoradiotherapy
- (2022) Lanqiong Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
- (2022) Weiwei Zeng et al. Advanced Science
- A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving
- (2021) Xiaojuan Zhang et al. Acta Pharmaceutica Sinica B
- Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy
- (2021) Hao Ren et al. Acta Pharmaceutica Sinica B
- Catalytically Active CoFe2O4 Nanoflowers for Augmented Sonodynamic and Chemodynamic Combination Therapy with Elicitation of Robust Immune Response
- (2021) Shiyan Fu et al. ACS Nano
- Cyclic reactions-mediated self-supply of H2O2 and O2 for cooperative chemodynamic/starvation cancer therapy
- (2021) Xiaojuan Zhang et al. BIOMATERIALS
- Symphony of nanomaterials and immunotherapy based on the cancer‒immunity cycle
- (2021) Qianqian Li et al. Acta Pharmaceutica Sinica B
- Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment
- (2020) Muhammad Ovais et al. ADVANCED MATERIALS
- MnO x Nanospikes as Nanoadjuvants and Immunogenic Cell Death Drugs with Enhanced Antitumor Immunity and Antimetastatic Effect
- (2020) Binbin Ding et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer
- (2020) Hong Xiang Zuo et al. JOURNAL OF ETHNOPHARMACOLOGY
- Tumor Microenvironment-Responsive Cu2(OH)PO4 Nanocrystals for Selective and Controllable Radiosentization via the X-ray-Triggered Fenton-like Reaction
- (2019) Chenyang Zhang et al. NANO LETTERS
- A Multifunctional Cascade Bioreactor Based on Hollow‐Structured Cu 2 MoS 4 for Synergetic Cancer Chemo‐Dynamic Therapy/Starvation Therapy/Phototherapy/Immunotherapy with Remarkably Enhanced Efficacy
- (2019) Mengyu Chang et al. ADVANCED MATERIALS
- Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects
- (2018) Lingtong Meng et al. ACS Nano
- Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reaction
- (2018) Zhongmin Tang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immunotherapy of cancers comes of age
- (2017) Hila Yousefi et al. Expert Review of Clinical Immunology
- Tumor-selective catalytic nanomedicine by nanocatalyst delivery
- (2017) Minfeng Huo et al. Nature Communications
- A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer
- (2016) Stephen M Hatfield et al. CURRENT OPINION IN PHARMACOLOGY
- Anticancer metal drugs and immunogenic cell death
- (2016) Alessio Terenzi et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes
- (2014) Alok D. Bokare et al. JOURNAL OF HAZARDOUS MATERIALS
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent
- (2010) Chen Yue-Jian et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- The redox state of glutathione regulates the hypoxic induction of HIF-1
- (2009) Masamichi Tajima et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
- (2009) K. Dietl et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started